Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists
Combining molecular modeling and in vitro bioassays, Sokkar et al. provide an understanding of how EPI-X4, an endogenous peptide antagonist, interacts with its receptor CXCR4. With computational model, validated by mutagenesis studies, they design a series of derivatives with optimized receptor anta...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f993d3d26776456ebe0fc89bf8e4a5df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f993d3d26776456ebe0fc89bf8e4a5df |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f993d3d26776456ebe0fc89bf8e4a5df2021-12-02T18:13:52ZComputational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists10.1038/s42003-021-02638-52399-3642https://doaj.org/article/f993d3d26776456ebe0fc89bf8e4a5df2021-09-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02638-5https://doaj.org/toc/2399-3642Combining molecular modeling and in vitro bioassays, Sokkar et al. provide an understanding of how EPI-X4, an endogenous peptide antagonist, interacts with its receptor CXCR4. With computational model, validated by mutagenesis studies, they design a series of derivatives with optimized receptor antagonizing properties as new leads for the development of CXCR4 inhibitors.Pandian SokkarMirja HarmsChristina StürzelAndrea GilgGönül KizilsavasMartina RaasholmNico PreisingManfred WagnerFrank KirchhoffLudger StändkerGilbert WeidingerBenjamin MayerJan MünchElsa Sanchez-GarciaNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biology (General) QH301-705.5 |
spellingShingle |
Biology (General) QH301-705.5 Pandian Sokkar Mirja Harms Christina Stürzel Andrea Gilg Gönül Kizilsavas Martina Raasholm Nico Preising Manfred Wagner Frank Kirchhoff Ludger Ständker Gilbert Weidinger Benjamin Mayer Jan Münch Elsa Sanchez-Garcia Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists |
description |
Combining molecular modeling and in vitro bioassays, Sokkar et al. provide an understanding of how EPI-X4, an endogenous peptide antagonist, interacts with its receptor CXCR4. With computational model, validated by mutagenesis studies, they design a series of derivatives with optimized receptor antagonizing properties as new leads for the development of CXCR4 inhibitors. |
format |
article |
author |
Pandian Sokkar Mirja Harms Christina Stürzel Andrea Gilg Gönül Kizilsavas Martina Raasholm Nico Preising Manfred Wagner Frank Kirchhoff Ludger Ständker Gilbert Weidinger Benjamin Mayer Jan Münch Elsa Sanchez-Garcia |
author_facet |
Pandian Sokkar Mirja Harms Christina Stürzel Andrea Gilg Gönül Kizilsavas Martina Raasholm Nico Preising Manfred Wagner Frank Kirchhoff Ludger Ständker Gilbert Weidinger Benjamin Mayer Jan Münch Elsa Sanchez-Garcia |
author_sort |
Pandian Sokkar |
title |
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists |
title_short |
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists |
title_full |
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists |
title_fullStr |
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists |
title_full_unstemmed |
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists |
title_sort |
computational modeling and experimental validation of the epi-x4/cxcr4 complex allows rational design of small peptide antagonists |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/f993d3d26776456ebe0fc89bf8e4a5df |
work_keys_str_mv |
AT pandiansokkar computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT mirjaharms computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT christinasturzel computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT andreagilg computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT gonulkizilsavas computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT martinaraasholm computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT nicopreising computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT manfredwagner computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT frankkirchhoff computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT ludgerstandker computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT gilbertweidinger computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT benjaminmayer computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT janmunch computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists AT elsasanchezgarcia computationalmodelingandexperimentalvalidationoftheepix4cxcr4complexallowsrationaldesignofsmallpeptideantagonists |
_version_ |
1718378489468420096 |